- Home
- SDHC vs TNDM Comparison
SDHC vs TNDM Comparison
Compare SDHC & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDHC
- TNDM
- Stock Information
- Founded
- SDHC 2008
- TNDM 2006
- Country
- SDHC United States
- TNDM United States
- Employees
- SDHC N/A
- TNDM N/A
- Industry
- SDHC
- TNDM Medical/Dental Instruments
- Sector
- SDHC
- TNDM Health Care
- Exchange
- SDHC Nasdaq
- TNDM Nasdaq
- Market Cap
- SDHC 933.4M
- TNDM 1.1B
- IPO Year
- SDHC 2024
- TNDM 2013
- Fundamental
- Price
- SDHC $18.78
- TNDM $19.82
- Analyst Decision
- SDHC Hold
- TNDM Buy
- Analyst Count
- SDHC 4
- TNDM 14
- Target Price
- SDHC $23.63
- TNDM $37.29
- AVG Volume (30 Days)
- SDHC 53.9K
- TNDM 1.5M
- Earning Date
- SDHC 05-14-2025
- TNDM 04-30-2025
- Dividend Yield
- SDHC N/A
- TNDM N/A
- EPS Growth
- SDHC N/A
- TNDM N/A
- EPS
- SDHC 0.24
- TNDM N/A
- Revenue
- SDHC $1,010,976,000.00
- TNDM $982,951,000.00
- Revenue This Year
- SDHC $6.51
- TNDM $8.91
- Revenue Next Year
- SDHC $11.93
- TNDM $11.04
- P/E Ratio
- SDHC $79.78
- TNDM N/A
- Revenue Growth
- SDHC 28.67
- TNDM 27.65
- 52 Week Low
- SDHC $16.28
- TNDM $15.75
- 52 Week High
- SDHC $39.50
- TNDM $53.69
- Technical
- Relative Strength Index (RSI)
- SDHC 50.39
- TNDM 42.87
- Support Level
- SDHC $16.28
- TNDM $20.22
- Resistance Level
- SDHC $18.45
- TNDM $21.99
- Average True Range (ATR)
- SDHC 1.18
- TNDM 0.93
- MACD
- SDHC 0.05
- TNDM -0.33
- Stochastic Oscillator
- SDHC 52.14
- TNDM 2.56
About SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.